Nvidia reported Q4 earnings Wednesday. Here are the key figures and a look at guidance. Will the results be enough to boost the stock and overall market?
Digital advertising platform Magnite (NASDAQ:MGNI) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.9% year on year to $205.4 million. Its non-GAAP profit of $0.34 per share was 3.9% below analysts’ consensus estimates.
Specialty insurance provider Fidelis Insurance (NYSE:FIHL) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 10.8% year on year to $600.9 million. Its non-GAAP profit of $1.09 per share was 1.3% above analysts’ consensus estimates.
Aerospace and defense company Redwire (NYSE:RDW) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 56.4% year on year to $108.8 million. The company’s full-year revenue guidance of $475 million at the midpoint came in 2.1% above analysts’ estimates. Its GAAP loss of $0.58 per share was significantly below analysts’ consensus estimates.
Nvidia’s outlook for the upcoming quarter topped Wall Street projections, with the company forecasting revenues of $78 billion, plus or minus 2%, against a consensus of $71.64 billion.
Leading designer of graphics chips Nvidia (NASDAQ:NVDA) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 73.2% year on year to $68.13 billion. On top of that, next quarter’s revenue guidance ($78 billion at the midpoint) was surprisingly good and 8.1% above what analysts were expecting. Its non-GAAP profit of $1.62 per share was 5.3% above analysts’ consensus estimates.
Healthcare services company Agilon Health (NYSE:AGL) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 3.1% year on year to $1.57 billion. On the other hand, next quarter’s revenue guidance of $1.37 billion was less impressive, coming in 12.6% below analysts’ estimates. Its GAAP loss of $0.46 per share was 69.1% below analysts’ consensus estimates.
Premium cinema technology company IMAX (NYSE:IMAX) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 35.1% year on year to $125.2 million. Its non-GAAP profit of $0.58 per share was 22.9% above analysts’ consensus estimates.
Hospital management company Universal Health Services (NYSE:UHS) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 9.1% year on year to $4.49 billion. On the other hand, the company’s full-year revenue guidance of $18.6 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $5.88 per share was 0.5% below analysts’ consensus estimates.
Digital auto insurance company Root (NASDAQ:ROOT) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 21.5% year on year to $397 million. Its GAAP profit of $0.31 per share was significantly above analysts’ consensus estimates.
